Legal & Regulatory

While FDA guidance on appropriate medical communication has evolved, US Dept. of Justice attention the practice is intensifying

Expect a flood of product-liability suits in the aftermath of Wyeth vs. Levine

Regulatory attention has intensified over commercial activities. Here’s what to do to minimize risks and raise compliance levels

Multiplying state laws on marketing and distribution disclosures might be pre-empted by new federal legislation

FDA specifies a patient registry and follow-up studies